Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional

A Study of the Safety and Tolerance of Long-Term Therapy With Intravenous Cytovene (Ganciclovir Sodium) for Cytomegalovirus Retinitis in Persons With AIDS

ClinicalTrials.gov ID: NCT00002034

Public ClinicalTrials.gov record NCT00002034. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 9:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT00002034
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
100 participants

Conditions and interventions

Interventions

  • Ganciclovir Drug
  • Zidovudine Drug

Drug

Eligibility (public fields only)

Age range
13 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Jun 23, 2005

United States locations

U.S. sites
8
U.S. states
7
U.S. cities
8
Facility City State ZIP Site status
Univ of Alabama at Birmingham Birmingham Alabama 35294
Summitt Med Ctr / San Francisco Gen Hosp Oakland California 94609
Stanford at Kaiser / Kaiser Permanente Med Ctr San Francisco California 94115
Miami Veterans Administration Med Ctr Miami Florida 33125
Dr Winkler Weinberg Roswell Georgia 30076
SUNY / Health Sciences Ctr at Stony Brook Stony Brook New York 117948153
Dr Alfred F Burnside Jr Columbia South Carolina 29204
Univ TX Galveston Med Branch Galveston Texas 77550

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00002034, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 23, 2005 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00002034 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →